CCK-AR Antibodies

Santa Cruz Biotechnology provides a broad selection of CCK-AR monoclonal antibodies for studying the cholecystokinin A receptor (CCK-AR). CCK-AR Antibodies are compatible with multiple research techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The cholecystokinin A receptor plays a crucial role in digestive processes and is involved in regulating satiety and gastrointestinal motility. CCK-AR's significance extends to various physiological functions, including the modulation of anxiety and pain perception. Understanding CCK-AR mechanisms can provide insights into therapeutic targets for gastrointestinal disorders and other related conditions. Research focusing on CCK-AR expression patterns helps illuminate its role in normal physiology and disease states. Investigating CCK-AR signaling pathways contributes to understanding cellular responses in different tissues. Exploring CCK-AR interactions with other molecular partners reveals complex regulatory networks. Santa Cruz Biotechnology monoclonal antibodies for CCK-AR support researchers worldwide in advancing scientific understanding of this essential receptor system.